BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 19589716)

  • 1. The Impact of the Course of Disease before Botulinum Toxin Therapy on the Course of Treatment and Long-Term Outcome in Cervical Dystonia.
    Hefter H; Schomaecker I; Schomaecker M; Rosenthal D; Samadzadeh S
    Toxins (Basel); 2021 Jul; 13(7):. PubMed ID: 34357965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brief considerations on the dispensation profile of the botulinum toxin type A by the Brazilian Unified Health System for treatment of dystonias: Datasus data.
    Chien HF; Rosso ALZ; Santos ASD; Rieder CRM; Maia DP; Silva DJD; Andrade MDC; Coletta MVD; Costa MDDLD; Allam N; Prado RCPD; Borges V; Tumas V; Horta WG
    eNeurologicalSci; 2016 Dec; 5():11-14. PubMed ID: 29430552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Abobotulinumtoxin A Treatment of Cervical Dystonia.
    Bentivoglio AR; Di Stasio E; Mulas D; Cerbarano ML; Ialongo T; Laurienzo A; Petracca M
    Neurotox Res; 2017 Aug; 32(2):291-300. PubMed ID: 28478527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective peripheral denervation for cervical dystonia: long-term follow-up.
    Bergenheim AT; Nordh E; Larsson E; Hariz MI
    J Neurol Neurosurg Psychiatry; 2015 Dec; 86(12):1307-13. PubMed ID: 25362089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review and meta-analysis of the duration of clinical effect of onabotulinumtoxinA in cervical dystonia.
    Marsh WA; Monroe DM; Brin MF; Gallagher CJ
    BMC Neurol; 2014 Apr; 14():91. PubMed ID: 24767576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical therapy program for cervical dystonia: a study of 20 cases.
    Queiroz MA; Chien HF; Sekeff-Sallem FA; Barbosa ER
    Funct Neurol; 2012; 27(3):187-92. PubMed ID: 23402680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of long-term botulinum toxin treatment in craniocervical dystonia: a systematic review.
    Colosimo C; Tiple D; Berardelli A
    Neurotox Res; 2012 Nov; 22(4):265-73. PubMed ID: 22359151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The therapeutic use of botulinum toxin in cervical and maxillofacial conditions: an evidence-based review.
    Ihde SK; Konstantinovic VS
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):e1-11. PubMed ID: 17560141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history of posttraumatic cervical dystonia.
    Frei KP; Pathak M; Jenkins S; Truong DD
    Mov Disord; 2004 Dec; 19(12):1492-8. PubMed ID: 15390063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical changes of cervical dystonia pattern in long-term botulinum toxin treated patients.
    Maia FM; Kanashiro AK; Chien HF; Gonçalves LR; Barbosa ER
    Parkinsonism Relat Disord; 2010 Jan; 16(1):8-11. PubMed ID: 19589716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Change in lateralization of the P22/N30 cortical component of median nerve somatosensory evoked potentials in patients with cervical dystonia after successful treatment with botulinum toxin A.
    Kanovský P; Streitová H; Dufek J; Znojil V; Daniel P; Rektor I
    Mov Disord; 1998 Jan; 13(1):108-17. PubMed ID: 9452335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of treatment of tardive dystonia and idiopathic cervical dystonia with botulinum toxin type A.
    Brashear A; Ambrosius WT; Eckert GJ; Siemers ER
    Mov Disord; 1998 Jan; 13(1):158-61. PubMed ID: 9452343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fast voluntary neck movements in patients with cervical dystonia: a kinematic study before and after therapy with botulinum toxin type A.
    Gregori B; Agostino R; Bologna M; Dinapoli L; Colosimo C; Accornero N; Berardelli A
    Clin Neurophysiol; 2008 Feb; 119(2):273-80. PubMed ID: 18063411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of cervical dystonia patients treated with botulinum toxin A.
    Haussermann P; Marczoch S; Klinger C; Landgrebe M; Conrad B; Ceballos-Baumann A
    Mov Disord; 2004 Mar; 19(3):303-8. PubMed ID: 15022184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injections.
    Slawek J; Friedman A; Potulska A; Krystkowiak P; Gervais C; Banach M; Ochudlo S; Budrewicz S; Reclawowicz D; Rynkowski M; Opala G
    Funct Neurol; 2007; 22(2):95-100. PubMed ID: 17637212
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.